Susunod

Auto-play

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 Mga view • 07/14/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play